ArticleTranslational lung cancer research2021

High indoleamine-2,3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC).

Florian Kocher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.